📌 Key Takeaways
- Topic: Silica for Refractory: Types, Properties and High-Temperature Applications
- Keywords: EMC filler
- Published: 2026-11-20 02:49:18
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Aerogel Powder: Properties, Applications and How It Compares to Other Insulators
- Fumed Silica 380 m²/g: Properties, Thickening Performance and Applications
- Sibelco Quartz: Product Range, Purity Grades and Applications
- Silica as a Thixotropic Agent: Mechanism, Dosage and Applications
- Fumed Silica vs Precipitated Silica: Differences in Production, Properties and Uses
- Fang, J. et al. Albumin-MnO 2 gated hollow mesoporous silica nanosystem for modulating tumor hypoxia and synergetic therapy of cervical carcinoma. Coll. Surf. B Biointerfac. 179, 250-259 (2019). Article CAS Google Scholar
What Is Silica Powder? Types, Particle Sizes, Grades and Common Applications
What is silica (SiO₂)?
silica anti caking agent Gu, T. et al. Platinum nanoparticles to enable electrodynamic therapy for effective cancer treatment. Adv. Mater. 31, 1806803 (2019). Article Google Scholar
What is the difference between fumed silica and precipitated silica?
silica surface area
What drives silica raw material prices?
silica manufacturer India MSNs-based scaffolds can enhance the cell proliferation, migration, adhesion and differentiation in bone tissue engineering. Many studies have systematically investigated and revealed the function of MSNs-based scaffolds in the regulation of cellular functions. 483, 484, 485, 486 Bone defects-involved regenerative mend is challenging to obtain a desired outcome due to the delay of early vascularization and poor osteogenic activity of bone implants. In this regard, researchers have designed a polycaprolactone network containing vascular-like structure, and introduced a nanofibrous gelatin-silica scaffold into it. Dimethyloxalylglycine (DMOG) and peptide-1 (BFP) were then loaded into MSNs, and the differential spatial distribution and sequential release of DMOG and BFP allowed the bioactive scaffold to promote angiogenesis by stimulating the migration of human umbilical vein endothelial cells (HUVECs), the tube formation and the expression of angiogenesis-related genes/proteins (HIF-1α, e-NOS, KDR and VEGF), as well as enhance osteogenesis by upregulating the expression of bone marrow-derived mesenchymal stem cells (BMSCs)-related osteogenic genes (Runx2, Col I, OPN and OCN) and promoting mineral matrix formation. 487 Apart from, Mora-Raimundo et al. reported MSNs as a nanocarrier to deliver SOST small interfering RNA (siRNA) and osteostatin, and the as-designed system could be used for osteoporosis remission via enhancing the bone microarchitecture. 379 Wang et al. designed a biomimetic silica-collagen scaffold via a robust biosilicification tactic, and the silica-collagen scaffold could mimic the distinctive microenvironment of bone extracellular matrix (ECM), resulting in the improvement of mesenchymal stem cell (MSC) recruitment and bone repair. 488 These MSNs-based scaffolds have excellent potential for clinical translation in the treatment of bone defects.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.